about
Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activationImpaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.Effects of progesterone and medroxyprogesterone on actin remodeling and neuronal spine formation.Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates.Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.Midlife predictors of Alzheimer's disease.Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APPSex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.Targeting gonadotropins: an alternative option for Alzheimer disease treatment.Maternal bisphenol A (BPA) decreases attractiveness of male offspringRegional-specific effects of ovarian hormone loss on synaptic plasticity in adult human APOE targeted replacement mice.Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women.Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life.The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.Is research on hormones and aging finished? No! Just started!Sex differences in the physiology and pharmacology of the lower urinary tract.17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain.Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer's disease.Exosomes in the Diseased Brain: First Insights from In vivo Studies.Neurogenesis in Alzheimer's disease.Why estrogens matter for behavior and brain health.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.17beta-estradiol attenuates hyperoxia-induced apoptosis in mouse C8-D1A cell line.Estradiol attenuates hyperoxia-induced cell death in the developing white matter.Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women.Estradiol enhances long term potentiation in hippocampal slices from aged apoE4-TR mice.An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats.Influence of variation in the follicle-stimulating hormone receptor gene (FSHR) and age at menopause on the development of Alzheimer's disease in women.Gonadal steroids do not affect apolipoprotein E expression in aging mouse cerebral cortex.Factors related to cognitive status among elders in southern Thailand.Gene expression analyses reveal molecular relationships among 20 regions of the human CNS.Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.Nonestrogen-based hormonal therapies for Alzheimer’s disease
P2860
Q21132562-71A6BB30-99F2-4EBD-B583-8AA4BF10A885Q33359590-A5900F13-A69A-4E41-B5FA-122F8A2AF917Q33635883-55B30748-5650-4963-813E-DE9460E6A31AQ33779001-5D0D86C3-9F12-4695-8042-F907D9AB652EQ33915170-856AB28B-C388-4A7C-9192-983C4D138542Q33956934-043DF415-1A09-4E2A-9B3F-5F2C3111C2EBQ34244907-012E741E-F82A-4C6A-8F25-2684B49BA500Q34311248-56256546-7F0C-4B7F-BA56-43C93BDF33C4Q34332342-8140A41D-5109-48AF-A3B1-434C68DCA625Q34541972-1A5AA1EB-F8E5-40D6-BA94-1DCB585825D2Q35016901-F32C8D17-DCC2-40D3-91EF-F2579AFD3AE7Q35105306-99E8E8FD-52DF-4149-9CBA-DBDB60C774CBQ35147562-9A2AE874-DC44-45AD-84B2-EB630FC55A93Q36069430-203CD1D6-033E-456A-B546-AA8761C250C8Q36456541-0BD6D0F1-35DA-4569-B6D6-9381C871025DQ36497060-169FA425-33DE-4F5D-A735-5EAEAF0252E2Q36687669-A001D0B5-3658-41C6-9B3B-DAAC839C67BCQ37020195-FC648623-362D-4E26-A952-0688F2F8C0E6Q37174865-349F7EF0-FD34-472F-A19B-2A64139E2AAFQ37198062-2586EA63-45F2-422B-A686-FD29B87F3F11Q37405017-75284986-206B-4F85-9BC7-551E21A7AC7CQ37427295-159D6685-37E2-43FC-9B3F-A31D8DD9D29EQ37716769-5BD416BB-EDE4-4A5C-8397-9DCBEBCBF31CQ37842603-996BEB50-E8E5-40F8-9D05-0824A38A8F27Q38796711-74552FB6-6EB1-4601-BA2A-CE0BAAF0F2B8Q39178920-63188B9A-9B10-4AA3-B73A-C8ED2E78B77FQ39962586-ADE82200-F035-4C64-A517-3B95F0385A0EQ40146979-EF4755BB-FB17-48B2-A1BB-BBE115D6AE18Q40238961-0E6C10FE-C8F3-4C24-8843-6DBCB64AFCBFQ42517451-FE0DCA66-3960-4C6B-B6D4-61AA159C5A10Q47355534-36DF16A7-1ED4-4B52-A662-3E5981204237Q48101664-94513BF6-4AA5-4555-B7E8-E5CDC53E5148Q50789441-D134839D-F2BB-497F-97FB-E15D7E99163CQ51528565-3754950A-94FC-497A-A04C-BAB8269E646DQ51684091-E829F1AC-85FF-466B-B754-E62404E8A33FQ52022087-2ADF3DF7-5B73-4456-A8CB-AC52AD41AB06Q55262740-318BDA45-7F6D-4174-8F90-2DFFC339B13AQ57341506-74A86631-C987-40F0-951F-00D40888DD52
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Sex, hormones, and Alzheimer's disease.
@ast
Sex, hormones, and Alzheimer's disease.
@en
type
label
Sex, hormones, and Alzheimer's disease.
@ast
Sex, hormones, and Alzheimer's disease.
@en
prefLabel
Sex, hormones, and Alzheimer's disease.
@ast
Sex, hormones, and Alzheimer's disease.
@en
P2860
P356
P1476
Sex, hormones, and Alzheimer's disease.
@en
P2093
Larry W Baum
P2860
P304
P356
10.1093/GERONA/60.6.736
P407
P577
2005-06-01T00:00:00Z